Skip to main content

Advertisement

Log in

Sleep and Cognitive Impairments in Neurodegenerative Diseases

  • Published:
Neuroscience and Behavioral Physiology Aims and scope Submit manuscript

Impairments of sleep and waking in diseases such as Parkinson’s disease, dementia, Lewy body dementia, and Alzheimer’s disease are encountered in a large proportion of patients. Sleep has many functions, supporting the normal operation of the brain, and impairments to sleep may be among the factors promoting the development of neurodegenerative diseases. Impairments to sleep and waking may exacerbate the course of the neurodegenerative process and lead to increases in symptoms, including cognitive impairments. This article presents a detailed analysis of the literature linking sleep and waking impairments and cognitive impairments in neurodegenerative diseases. The phenomenology and methods of correcting sleep and waking impairments in these diseases are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. L. Xie, H. Kang, Q. Xu, et al., “Sleep drives metabolite clearance from the adult brain,” Science, 342, No. 6156, 373–377 (2013), https://doi.org/10.1126/science.1241224.

    Article  CAS  PubMed  Google Scholar 

  2. S. Bombois, P. Derambure, F. Pasquier, and C. Monaca, “Sleep disorders in aging and dementia,” J. Nutr. Health Aging, 14, No. 3, 212–217 (2010).

    Article  CAS  Google Scholar 

  3. D. J. Ley, A. A. Monjan, S. L. Brown, et al., “Sleep complaints among elderly persons: an epidemiologic study of three communities,” Sleep, 18, 425–432 (1995).

    Article  Google Scholar 

  4. Y. E. Ju, J. S. McLeland, C. D. Toedebusch, et al., “Sleep quality and preclinical Alzheimer disease,” JAMA Neurol., 70, No. 5, 587–593 (2013), https://doi.org/10.1001/jamaneurol.2013.2334.

    Article  PubMed  PubMed Central  Google Scholar 

  5. J. Backhaus, J. Born, R. Hoeckesfeld, et al., “Midlife decline in declarative memory consolidation is correlated with a decline in slow wave sleep,” Learn. Mem., 14, No. 5, 336–341 (2007), https://doi.org/10.1101/lm.470507.

    Article  PubMed  PubMed Central  Google Scholar 

  6. J. C. Lo, J. A. Groeger, G. H. Cheng, et al., “Self-reported sleep duration and cognitive performance in older adults: a systematic review and meta-analysis,” Sleep Med., 17, 87–98 (2016), https://doi.org/10.1016/j.sleep.2015.08.021.

    Article  PubMed  Google Scholar 

  7. J. Benito-Leon, E. D. Louis, and F. Bermejo-Pareja, “Cognitive decline in short and long sleepers: a prospective population-based study (NEDICES),” J. Psychiatr. Res., 47, No. 12, 1998–2003 (2013), https://doi.org/10.1016/j.jpsychires.2013.09.007.

    Article  PubMed  Google Scholar 

  8. G. Merlino, A. Piani, G. L. Gigli, et al., “Daytime sleepiness is associated with dementia and cognitive decline in older Italian adults: a population-based study,” Sleep Med., 11, No. 4, 372–377 (2010),https://doi.org/10.1016/j.sleep.2009.07.018.

    Article  CAS  PubMed  Google Scholar 

  9. D. Foley, A. Monjan, K. Masaki, et al., “Daytime sleepiness is associated with 3-year incident dementia and cognitive decline in older Japanese-American men,” J. Am. Ger. Soc., 49, No. 12, 1628–1632 (2001), https://doi.org/10.1111/j.1532-5415.2001.49271.x.

    Article  CAS  Google Scholar 

  10. N. E. Cross, J. Lagopoulos, S. L. Duffy, et al., “Sleep quality in healthy older people: relationship with 1H magnetic resonance spectroscopy markers of glial and neuronal integrity,” Behav. Neurosci., 127, No. 5, 803–810 (2013),https://doi.org/10.1037/a0034154.

    Article  CAS  PubMed  Google Scholar 

  11. O. V. Babkina, M. G. Poluektov, and O. S. Levin, “Heterogenity of daytime drowsiness in Parkinson’s disease,” Zh. Nevrol. Psikhiat., 116, No. 6, Iss. 2, 60–70 (2016), https://doi.org/10.17116/jnevro20161166260-70.

  12. G. Tononi and C. Cirelli, “Sleep and the price of plasticity: from synaptic and cellular homeostasis to memory consolidation and integration,” Neuron, 81, No. 1, 12–34 (2014).

    Article  CAS  Google Scholar 

  13. J. Zhang, Y. Zhu, G. Zhan, et al., “Extended wakefulness: compromised metabolics in and degeneration of locus ceruleus neurons,” J. Neurosci., 34, No. 12, 4418–4431 (2014), https://doi.org/10.1523/JNEUROSCI.5025-12.2014.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. M. Matsumae, O. Sato, A. Hirayama, et al., “Research into the physiology of cerebrospinal fl uid reaches a new horizon: intimate exchange between cerebrospinal fl uid and interstitial fl uid may contribute to maintenance of homeostasis in the central nervous system,” Neurol. Med. Chir. (Tokyo), 56, No. 7, 416–441 (2016), https://doi.org/10.2176/nmc.ra.2016-0020.

    Article  Google Scholar 

  15. W. Peng, T. M. Achariyar, B. Li, et al., “Suppression of glymphatic fluid transport in a mouse model of Alzheimer’s disease,” Neurobiol. Dis., 93, 215–225 (2016).

    Article  CAS  Google Scholar 

  16. P. Venkat, M. Chopp, A. Zacharek, et al., “White matter damage and glymphatic dysfunction in a model of vascular dementia in rats with no prior vascular pathologies,” Neurobiol. Aging, 50, 96–106 (2017),https://doi.org/10.1016/j.neurobiolaging.2016.11.002.

    Article  PubMed  Google Scholar 

  17. D. M. Zeppenfeld, M. Simon, J. D. Haswell, et al., “Association of perivascular loalization of aquaporin-4 with cognition and Alzheimer disease in aging brains,” JAMA Neurol., 74, No. 1, 91 (2017), https://doi.org/10.1001/jamaneurol.2016.4370.

    Article  PubMed  Google Scholar 

  18. K. G. Burfeind, C. F. Murchison, S. K. Westaway, et al., “The effects of noncoding aquaporin-4 single-nucleotide polymorphisms on cognition and functional progression of Alzheimer’s disease,” Alzheim. Dement. (NY), 3, No. 3, 348–359 (2017), https://doi.org/10.1016/j.trci.2017.05.001.

  19. A. P. Spira, L. P. Chen-Edinboro, M. N. Wu, and K. Yaffe, “Impact of sleep on the risk of cognitive decline and dementia,” Curr. Opin. Psychiatry, 27, No. 6, 478–483 (2014).

    Article  Google Scholar 

  20. H. H. Weng, Y. H. Tsai, C. F. Chen, et al., “Mapping gray matter reductions in obstructive sleep apnea: an activation likelihood estima tion meta-analysis,” Sleep, 37, No. 1, 167–175 (2014), https://doi.org/10.5665/sleep.3330.

    Article  PubMed  PubMed Central  Google Scholar 

  21. A. M. V. Wennberg, M. N. Wu, P. B. Rosenberg, and A. P. Spira, “Sleep disturbance, cognitive decline, and dementia: A review,” Semin. Neurol., 37, No. 4, 395–406 (2017).

    Article  Google Scholar 

  22. K. Gagnon, A. A. Baril, J. F. Gagnon, et al., “Cognitive impairment in obstructive sleep apnea,” Pathol. Biol. (Paris), 62, No. 5, 233–240 (2014), https://doi.org/10.1016/j.patbio.2014.05.015.

    Article  CAS  Google Scholar 

  23. C. Lal, C. Strange, and D. Bachman, “Neurocognitive impairment in obstructive sleep apnea,” Chest, 141, No. 6, 1601–1610 (2012), https://doi.org/10.1378/chest.11-2214.

    Article  PubMed  Google Scholar 

  24. O. S. Levin and N. V. Fedorova, Parkinson’s Disease, MEDpress- Inform (2012), 2nd ed.

  25. A. Ylikoski, K. Martikainen, M. Sieminski, and M. Partinen, “Parkinson’s disease and insomnia,” Neurol. Sci., 36, No. 11, 2003–2010 (2015), https://doi.org/10.1007/s10072-015-2288-9.

    Article  PubMed  Google Scholar 

  26. E. A. Lyashenko, O. S. Levin, and M. G. Poluektov, “Use of mega for correction of behavioral disorders in the rapid eye movement phase of sleep in Parkinson’s disease,” Zh. Nevrol. Psikhiat., Spec. Issue, 115, No. 6, Iss. 2, 40–43 (2015), https://doi.org/10.17116/jnevro20151156240-43.

  27. Y. E. Kim and B. S. Jeon, “Clinical implication of REM sleep behavior disorder in Parkinson’s disease,” J. Parkinsons Dis., 4, No. 2,237–244 (2014), https://doi.org/10.3233/JPD-130293.

    Article  CAS  Google Scholar 

  28. O. V. Babkina, M. G. Poluektov, and O. S. Levin, “ Disruption to circadian regulatory mechanisms in age-dependent neurodegenerative diseases,” Effektiv. Farmakoter., 35, 114–122 (2017).

    Google Scholar 

  29. M. D. Gjerstad, O. B. Tysnes, and J. P. Larsen, “Increased risk of leg motor restlessness but not RLS in early Parkinson disease,” Neurology, 77, No. 22, 1941–1946 (2011), https://doi.org/10.1212/WNL.0b013e31823a0cc8.

  30. S. Kumar, M. Bhatia, and M. Behari, “Sleep disorders in Parkinson’s disease,” Mov. Disord., 4, 775–778 (2002), https://doi.org/10.1002/mds.10167.

  31. X. Y. Zhu, Y. Liu, X. J. Zhang, https://doi.org/10.1212/WNL.0b013e31823a0cc8”Clinical characteristics of leg restlessness in Parkinson’s disease compared with idiopathic Restless Legs Syndrome,” J. Neurol. Sci., 357, No. 1–2, 109–114 (2015), https://doi.org/10.1016/j.jns.2015.07.008.

  32. T. Simuni, C. Caspell-Garcia, C. Coffey, et al., PPMI Sleep Working Group on behalf of the PPMI Investigators, “Correlates of excessive daytime sleepiness in de novo Parkinson’s disease: A case control study,” Mov. Disord., 30, No. 10, 1371–1381 (2015).

  33. S. Kato, H. Watanabe, J. Senda, et al., “Widespread cortical and subcortical brain atrophy in Parkinson’s disease with excessive daytime sleepiness,” J. Neurol., 259, No. 2, 318–326 (2012), https://doi.org/10.1007/s00415-011-6187-6.

    Article  CAS  PubMed  Google Scholar 

  34. O. V. Yakovleva, M. G. Poluektov, O. S. Levin, and E. A. Lyashenko, “Sleep and waking disiorders in neurodegenerative diseases,” Zh. Nevrol. Psikhiat., Spec. Issue, 118, No. 4, 83–91 (2018).

  35. N. J. Diederich, M. Vaillant, M. Leischen, et al., “Sleep apnea syndrome in Parkinson’s disease. A case-control study in 49 patients,” Mov. Disord., 20, No. 11, 1413–1418 (2005).

    Article  Google Scholar 

  36. A. Cagnin, F. Fragiacomo, G. Camporese, et al., “Sleep-wake profi le in dementia with Lewy bodies, Alzheimer’s disease, and normal aging,” J. Alzheim. Dis., 55, No. 4, 1529–1536 (2017), https://doi.org/10.3233/JAD-160385.

    Article  CAS  Google Scholar 

  37. I. G. McKeith, B. F. Boeve, D. W. Dickson, et al., “Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium,” Neurology, 89, No. 1, 88–100 (2017).

    Article  Google Scholar 

  38. F. Boddy, E. N. Rowan, D. Lett, et al., “Subjectively reported sleep quality and excessive daytime somnolence in Parkinson’s disease with and without dementia, dementia with Lewy bodies and Alzheimer’s disease,” Int. J. Geriatr. Psychiatry, 22, No. 6, 529–535. (2007).

    Article  Google Scholar 

  39. C. R. Baumann, Y. Dauvilliers, E. Mignot, and C. L. Bassetti, “Normal CSF hypocretin-1 (orexin A) levels in dementia with Lewy bodies associated with excessive daytime sleepiness,” Eur. Neurol.,52, 73–76 (2004).

    Article  CAS  Google Scholar 

  40. B. Guarnieri, F. Adorni, M. Musicco, et al., “Prevalence of sleep disturbances in mild cognitive impairment and dementing disorders: a multicenter Italian clinical cross-sectional study on 431 patients,” Dement. Geriatr. Cogn. Disord., 33, No. 1, 50–58 (2012).

    Article  CAS  Google Scholar 

  41. S. Hibi, Y. Yamaguchi, Y. Umeda-Kameyama, et al., “The high frequency of periodic limb movements in patients with Lewy body dementia,” J. Psychiatr. Res., 46, 1590–1594 (2012).

    Article  Google Scholar 

  42. J. Yesavage, L. F. Friedman, H. C. Kraemer, et al., “A follow-up study of actigraphic measures in home-residing Alzheimer’s disease patients,” J. Geriatr. Psychiatry Neurol., 11, No. 1, 7–10 (1998),https://doi.org/10.1177/089198879801100103.

    Article  CAS  PubMed  Google Scholar 

  43. C. Schenck, B. Boeve, and M. Mahowald, “Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series,” Sleep Med., 14, No. 8, 744–748 (2013), https://doi.org/10.1016/j.sleep.2012.10.009.

    Article  PubMed  Google Scholar 

  44. D. P. Cardinali, A. M. Furio, and L. I. Brusco, “Clinical aspects of melatonin intervention in Alzheimer’s disease progression,” Curr. Neuropharmacol., 8, No. 3, 218–227 (2010).

    Article  CAS  Google Scholar 

  45. K. E. Moe, M. V. Vitiello, L. H. Larsen, and P. N. Prinz, “Symposium: Cognitive processes and sleep disturbances: Sleep/wake patterns in Alzheimer’s disease: relationships with cognition and function,” J. Sleep Res., 4, No. 1, 15–20 (1995).

    Article  CAS  Google Scholar 

  46. L. Volicer, D. G. Harper, B. C. Manning, et al., “Sundowning and circadian rhythms in Alzheimer’s disease,” Am. J. Psychiatry, 158, No. 5, 704–711 (2001), https://doi.org/10.1176/appi.ajp.158.5.704.

    Article  CAS  Google Scholar 

  47. T. J. Ferman, G. E. Smith, D. W. Dickson, et al., “Abnormal daytime sleepiness in dementia with Lewy bodies compared to Alzheimer’s disease using the multiple sleep latency test,” Alzheim. Res. Ther., 6, No. 9, 76 (2014), https://doi.org/10.1186/s13195-014-0076-z.

    Article  Google Scholar 

  48. M. Cohen-Zion, C. Stepnowsky, Marler, et al., “Changes in cognitive function associated with sleep disordered breathing in older people,” J. Am. Geriatr. Soc., 49, No. 12, 1622–1627 (2001), https://doi.org/10.1046/j.1532-5415.2001.t01-1-49270.x.

    Article  CAS  PubMed  Google Scholar 

  49. F. Onen and H. Onen, “Obstructive sleep apnea and cognitive impairment in the elderly,” Psychol. Neuropsychiatr. Vieil., 8, 163–169 (2010), https://doi.org/10.1684/pnv.2010.0219.

    Article  PubMed  Google Scholar 

  50. V. E. Pearson, R. P. Allen, T. Dean, et al., “Cognitive deficits associated with restless legs syndrome (RLS),” Sleep Med., 7, No. 1, 25– 30 (2006), https://doi.org/10.1016/j.sleep.2005.05.006.

    Article  PubMed  Google Scholar 

  51. S. Hood S and S. Amir, “Neurodegeneration and the circadian clock,” Front. Aging Neurosci., 9, 170 (2017).

    Article  Google Scholar 

  52. G. Dowling, J. Mastick, E. Colling, et al., “Melatonin for sleep disturbances in Parkinson’s disease,” Sleep Med., 6, No. 5, 459–466 (2005), https://doi.org/10.1016/j.sleep.2005.04.004.

    Article  PubMed  Google Scholar 

  53. C. Medeiros, P. Carvalhedo de Bruin, L. Lopes, et al., “Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson’s disease,” J. Neurol., 254, No. 4, 459–464 (2007), https://doi.org/10.1007/s00415-006-0390-x.

    Article  CAS  PubMed  Google Scholar 

  54. A. de Jonghe, J. Korevaar, B. van Munster, and S. de Rooij, “Effectiveness of melatonin treatment on circadian rhythm disturbances in dementia. Are there implications for delirium? A systematic review,” Int. J. Geriatr. Psychiatry, 25, No. 12, 1201–1208 (2010), https://doi.org/10.1002/gps.2454.

    Article  PubMed  Google Scholar 

  55. S. Ancoli-Israel, B. W. Palmer, J. R. Cooke, et al., “Cognitive effects of treating obstructive sleep apnea in Alzheimer’s disease: A randomized controlled study,” J. Am. Ger. Soc., 56, No. 11, 2076–2081 (2008), https://doi.org/10.1111/j.1532-5415.2008.01934.x.

    Article  Google Scholar 

  56. D. Kunz and F. Bes, “Melatonin as a therapy in REM sleep behavior disorder patients: an open-labeled pilot study on the possible infl uence of melatonin on REM-sleep regulation,” Mov. Disord., 14, 507–511 (1999).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to O. V. Yakovleva.

Additional information

Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 119, No. 4, Iss. 2, Insomnia, pp. 89–98, April, 2019.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yakovleva, O.V., Poluektov, M.G., Lyashenko, E.A. et al. Sleep and Cognitive Impairments in Neurodegenerative Diseases. Neurosci Behav Physi 50, 275–282 (2020). https://doi.org/10.1007/s11055-020-00898-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11055-020-00898-y

Keywords

Navigation